secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0000885725-25-000043
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific EVP/Peripheral Interventions President Mirviss to retire in Dec 2025
--------------------------------------------------------------------------------

- Jeffrey B. Mirviss will retire as EVP and President, Peripheral Interventions effective Dec 1, 2025.
- He will stay as senior advisor from Dec 1, 2025 through Feb 27, 2026 at $705,000 prorated salary.
- No successor named; retirement agreement mirrors terms under Executive Retirement Plan and incentive programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000043/0000885725-25-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000043/bsx-20250829.htm
  HTML page:      https://secwatch.observer/filing/0000885725-25-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer